Roche · 5 days ago
2026 Summer Intern - Discovery Chemistry
California
Internship
Onsite
Intern
$29/hr - $33/hr
Start in 2026 SpringRoche is a leading biotechnology company, and they are seeking a Summer Intern for their Discovery Chemistry department. The role involves hands-on synthetic work, critical thinking, and collaboration with industrial chemists to advance medicinal chemistry projects.
BiotechnologyHealth CareHealth DiagnosticsOncologyPharmaceuticalPrecision Medicine
Responsibilities
Interface with industrial chemists to explore and refine chemistry towards scaffolds relevant to medicinal chemistry
Perform hands-on synthetic work and optimization where necessary to advance an internship project
Gain experience with chemical synthesis techniques, including chemical catalysis and reactions essential to a professional career in medicinal chemistry
Apply critical thinking and problem-solving to achieve project goals
Contribute to Genentech’s culture of scientific curiosity and discovery via cross-department presentations
Qualification
Required
Must be pursuing a Bachelor's Degree (enrolled student)
Experience with multi-step small molecule organic synthesis
Familiarity with modern techniques for small molecule purification and analysis (NMR, LCMS)
Preferred
Excellent communication, collaboration, and interpersonal skills
Complements our culture and the standards that guide our daily behavior & decisions: Integrity, Courage, and Passion
Benefits
Paid holiday time off benefits
Company
Roche
Roche is a pharmaceutical and diagnostics company that offers medicines and diagnostic tests for various medical conditions and diseases.
Founded in 1896
10001+ employees
H1B Sponsorship
Roche has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (12)
2024 (9)
2023 (6)
2022 (2)
2021 (2)
Funding
Current Stage
Public CompanyTotal Funding
$7.79BKey Investors
SoftBankSCALE AINovartis
2021-08-04Post Ipo Equity· $5B
2020-12-07IPO
2020-05-06Post Ipo Equity· $0.5M
Leadership Team
Alan Hippe
Member of the Executive Board - Group CFO
Christine Bakan
Global Head and VP of Software and Bioinformatics, Next Generation Sequencing
Recent News
Pharmaceutical Technology
2026-01-13
2026-01-12
Company data provided by crunchbase